BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 12, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Posidur: Phase IIb data

In a double-blind, European Phase IIb trial in 115 patients undergoing open hysterectomy surgery, 5 mL Posidur met the co-primary endpoint of non-inferiority to placebo in terms of pain intensity 1-72 hours post-surgery, but missed the co-primary endpoint of superiority to placebo in...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >